Skip to main content

and
  1. No Access

    Article

    Application of a Gamma Model of Absorption to Oral Cyclosporin

    Background: Some drugs, such as cyclosporin, exhibit flat and delayed absorption profiles, with a correlation between the delay and the peak width. Such profiles can be described by an absorption...

    Dr Jean Debord, Eléonore Risco, Michel Harel, Yannick Le Meur in Clinical Pharmacokinetics (2001)

  2. No Access

    Article

    Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy

    Objectives: Area under the curve (AUC)-based monitoring of cyclosporin (CsA) could help to optimise therapeutic drug monitoring in certain transplant patients in addition to trough concentration ...

    Chantal Le Guellec, Matthias Büchler in European Journal of Clinical Pharmacology (2002)

  3. No Access

    Article

    A Double Absorption-Phase Model Adequately Describes Mycophenolic Acid Plasma Profiles in De Novo Renal Transplant Recipients Given Oral Mycophenolate Mofetil

    Mycophenolic acid (MPA) shows complex plasma concentrationtime profiles, particularly in the immediate (first month) post-transplantation phase for which no relevant pharmacokinetic model has been proposed thu...

    Aurélie Prémaud, Jean Debord, Annick Rousseau, Yannick Le Meur in Clinical Pharmacokinetics (2005)

  4. No Access

    Article

    Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients

    Objectives: The aims of this study were (i) to investigate the population pharmacokinetics of tacrolimus in renal transplant recipients, including the influence of biological and pharmacogenetic ...

    Khaled Benkali, Aurelie Prémaud, Nicolas Picard in Clinical Pharmacokinetics (2009)

  5. No Access

    Article

    Glomerular Antibodies in Lupus Nephritis

    Lupus nephritis (LN) remains the most common severe manifestation of systemic lupus erythematosus (SLE) characterized by the presence of autoantibodies (Abs) that are believed to play a central role in the pat...

    Catherine Hanrotel-Saliou, Isabelle Segalen in Clinical Reviews in Allergy & Immunology (2011)

  6. No Access

    Article

    Kidney volume—a crystal ball for ADPKD prognosis?

    A new study has addressed a key question in autosomal dominant polycystic kidney disease (ADPKD): can we predict renal outcome at an early disease stage? Indeed, this information is useful for any patient with...

    Emilie Cornec-Le Gall, Yannick Le Meur in Nature Reviews Nephrology (2014)

  7. Article

    Open Access

    Novel long-range regulatory mechanisms controlling PKD2 gene expression

    Cis-regulatory elements control gene expression over large distances through the formation of chromatin loops, which allow contact between enhancers and gene promoters. Alterations in cis-acting regulatory system...

    Stéphanie Moisan, Stéphanie Levon, Emilie Cornec-Le Gall, Yannick Le Meur in BMC Genomics (2018)

  8. Article

    Open Access

    EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial

    Despite advances in immunosuppressive therapy, kidney graft survival has failed to improve during the last decades. Ischemia/reperfusion injury (IRI) is one of the main pathophysiological mechanisms underlying...

    Sophie Girerd, Luc Frimat, Didier Ducloux, Yannick Le Meur, Christophe Mariat in Trials (2018)

  9. Article

    Open Access

    Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

    Different prolonged-release formulations of tacrolimus are available. To date, the pharmacokinetic (PK) profile of LCP-tacrolimus (LCPT; Envarsus®) has not been compared with PR-Tac (Advagraf®) in de novo kidney ...

    Nassim Kamar, Elisabeth Cassuto, Giovanni Piotti, Mirco Govoni in Advances in Therapy (2019)

  10. Article

    Open Access

    Evaluation of the efficacy of HEMO2life®, a marine OXYgen carrier for Organ Preservation (OxyOp2) in renal transplantation: study protocol for a multicenter randomized trial

    Preventing ischemia‒reperfusion injury (IRI) is a major issue in kidney transplantation, particularly for transplant recipients receiving a kidney from extended criteria donors (ECD). The main consequence of I...

    Yannick Le Meur, Emmanuel Nowak, Benoit Barrou, Antoine Thierry, Lionel Badet in Trials (2023)